ORPIANESI, EMANUELA
ORPIANESI, EMANUELA
Dipartimento di Scienze della Salute
Anti-EGFR antibody reduces lung nodules by inhibition of EGFR-pathway in a model of lymphangioleiomyomatosis
2015 E. Lesma, E. Chiaramonte, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Characterization of human TSC2 cells derived from a TSC/LAM patient chylous effusion
2011 E. Lesma, S. Ancona, V. Grande, S.M. Sirchia, E. Orpianesi, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Chromatin remodelling by rosuvastatin normalizes TSC2-/meth cell phenotype through the expression of tuberin
2013 E. Lesma, S. Ancona, E. Orpianesi, V. Grande, A.M. Di Giulio, A. Gorio
Development of a cutaneous mouse model of TSC and LAM by injection of human tuberin-deficient cells : effects of chromatin remodelling agents
2013 E. Lesma, C. Bernardelli, E. Chiaramonte, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Development of a lymphangioleiomyomatosis model by endonasal administration of human TSC2-/- smooth muscle cells in mice
2012 E. Lesma, E. Chiaramonte, E. Isaia, V. Grande, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells
2021 S. Ancona, E. Orpianesi, C. Bernardelli, E. Chiaramonte, R. Chiaramonte, S. Terraneo, F. Di Marco, E. Lesma
Direct and indirect pharmacological regulation of mTOR affects fate of LAM/TSC cells. Epithelial to mesenchymal transition features of LAM/TSC cells
2013 S. Ancona, E. Lesma, S.M. Sirchia, E. Orpianesi, A.M. Di Giulio, A. Gorio
Human LAM/TSC cells efficiently cause lung nodule formation and alveolar destruction. Pharmacological counteraction by modulation of mTOR activity
2013 E. Chiaramonte, E. Lesma, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
LAM/TSC CELLS BEARING A TSC2 MUTATION SECRETE CHEMOKINES AND MATRIXMETHALLOPROTEINASES
2012 E. Orpianesi, S. Ancona, V. Grande, E. Lesma, A.M. Di Giulio, A. Gorio
LAM/TSC cells cause pulmonary nodule development by endonasal administration in nude mice
2012 E. Chiaramonte, C. Bernardelli, S. Ancona, E. Orpianesi, E. Lesma, A.M. Di Giulio, A. Gorio
Matrix methalloproteinase 2 and 7 are new targets in LAM and TSC-related disorders
2013 E. Orpianesi, E. Lesma, S. Ancona, E. Chiaramonte, A.M. Di Giulio, A. Gorio
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT
2012 S. Ancona, E. Lesma, E. Orpianesi, R. Chiaramonte, L. Mirandola, A.M. Di Giulio, A. Gorio
Role of chemokines in tuberous sclerosis and lymphangioleiomyomatosis
2011 E. Orpianesi
ROSUVASTATIN ACTING AS A DEMETHYLATING AGENT AFFECTS PROLIFERATION OF TSC2-/meth ASM CELLS
2012 V. Grande, E. Lesma, S. Ancona, E. Orpianesi, A.M. Di Giulio, A. Gorio
STUDIO DELLE CITOCHINE E DELLE METALLOPROTEASI NELLA LINFANGIOLEIOMIOMATOSI E NELLA SCLEROSI TUBEROSA
2014 E. Orpianesi
TSC2 epigenetic defect in primary LAM cells. Evidence of an anchorage-independent survival
2014 E. Lesma, S. Ancona, S.M. Sirchia, E. Orpianesi, V. Grande, P. Colapietro, E. Chiaramonte, A.M. Di Giulio, A. Gorio
Tuberin deficiency for an epigenetic modification in LAM cells from chylous of a TSC2 patient
2012 E. Lesma, S. Ancona, S.M. Sirchia, V. Grande, E. Orpianesi, R.M. Alfano, A.M. Di Giulio, A. Gorio